Aseptika recognised as leading HealthTech Innovator with listing 2017 Global Digital Health 100

ST IVES, U.K. - Jan. 21, 2018 - PRLog -- The Global Digital Health 100 is one of the HealthTech industries foremost technology award programmes, celebrating innovation and entrepreneurship. It recognises and supports health technology companies that are demonstrating the greatest potential to change the way that healthcare is delivered. Over the past four years, the Global Digital Health 100 has become established as the international benchmark of innovation in the healthcare technology industry and this is the third time Aseptika (Activ8rlives) has been included in the top 100.  For more details and to view the full 2017 Global Digital Health 100 visit thejournalofmhealth.com/digital-health-100.

Digital Health is Maturing
The awards programme run by the Journal of mHealth commented, "reflect the ever-growing importance of mobile, digital and connected solutions in the healthcare industry, the Global Digital Health 100-2017 recognises the significant work being carried out by organisations from around the globe.

While many companies, over the past few years, have failed despite having truly innovative technologies to offer, the 2017 cohort shows that it is essential to not only demonstrate innovation in technology, but also innovation in service and business model development as a requisite to succeeding as a technology company in the healthcare industry".

Identifying the 100
The judging criteria analysed 10 different quantitative and qualitative evaluation metrics including: disruptive impact; proof of concept; technology innovation; social value; effectiveness; execution of strategy; and, industry integration. The selected 100 companies demonstrate true innovation and the opportunity to disrupt the delivery of healthcare at scale. The selection criteria ensure that companies are considered truly upon innovation, allowing start-up offerings to be compared alongside established and larger organisations.

Ends

For more information, please visit: www.activ8rlives.com

Activ8rlives, Activ8rlives.com and Active⁺ are trademarks of Aseptika Ltd.

About Aseptika Limited (Activ8rlives) www.activ8rlives.com

Aseptika Ltd began developing Activ8rlives in 2010 and is currently developing its third generation of integrated systems, which can be used by consumers and their healthcare service providers using a wide range of platforms or devices to better enable effective and easy self-monitoring. Incorporating sensors and monitors ranging from consumer accessories to in vitro diagnostics (IVDs). Our focus is: respiratory and cardiovascular disease, cancer, promoting physical activity, and weight management.

Active⁺ rehabilitation classes integrating Activ8rlives self-monitoring technology began with cardiac rehabilitation classes. These classes have now been extended to include people with cancer in partnership with a local cancer charity HCCN who has pioneered a new exercise programme for patients before during and immediately after their treatment. Active⁺ is the result of a collaboration between Huntingdonshire District Council (HDC) Active Lifestyles, Huntingdonshire Community Cancer Network (HCCN) and enabled with Aseptika's innovative Activ8rlives health platform and supported by Eastern Academic Health Science Network (Eastern AHSN). This cross-organisational collaboration has been key to its success and deployment – a model Eastern AHSN is hoping to replicate across the Eastern region to reduce the workload of over-stretched NHS Hospitals.